Pacific Biosciences Of California (PACB) Acquisitions (2021)
Pacific Biosciences Of California (PACB) recorded quarterly Acquisitions of $291.2 million in Q4 2021.
Pacific Biosciences Of California (PACB) Acquisitions (2021) Analysis & Trends
Pacific Biosciences Of California's Acquisitions history runs 1 years deep, the most recent figure standing at $291.2 million for Q4 2021.
- In Q4 2021, Acquisitions changed N/A year-over-year to $291.2 million; the TTM figure through Dec 2024 stood at $291.2 million (changed N/A YoY), while the FY2023 annual figure was $102000.0, changed N/A from the prior year.
- Acquisitions was $291.2 million for Q4 2021 at Pacific Biosciences Of California.
- In the past five years, Acquisitions ranged from a high of $291.2 million in Q4 2021 to a low of $291.2 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 22.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 523.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -268.10 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 2.30 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Pacific Biosciences Of California | 426.62 Mn | 150.66 Mn | 12.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 291.23 Mn |